 |
 |
 |
|
Steve
Norton, CLT-LANA
MLD/CDT Instructor
Founder
In 1993 Steve received additional
training in Manual Lymph Drainage and Complete Decongestive Therapy
at Lerner Lymphedema Services, the first fully specialized lymphedema
treatment facility in the United States. He advanced to Chief Therapist
of the Lerner Lymphedema Services clinics located in Princeton,
NJ, Manhattan, NYC, and New Brunswick, NJ, 1994-1999. In 1995 and
1999 Steve completed further educational programs in lymphedema
management at the Foeldi College in Hinterzarten, Germany. In addition
to his clinical duties, he was asked to provide instructional services
in MLD/CDT at the Lerner Lymphedema Services Academy of Lymphatic
Studies, a premier educational program for lymphedema specialists.
In 1998 Steve co-founded an independent training and consulting
company, the Klose Norton School of Lymphedema Therapy, offering
MLD/CDT certification programs for medical professionals in various
hospitals and clinical settings nationwide.
Currently, as a consultant and
MLD/CDT Instructor, Steve continues to provide instructional and
consultation services to private clinics, hospitals, independent
physician's offices, and firms within the lymphedema and related
compression therapy industries. He has authored articles on lymphedema
management in professional publications and regularly reviews lymphedema-related
manuscripts. He has contributed to chapters and editorial revisions
of the internationally-renowned "Textbook of Lymphology" by
Professor M. Foeldi & S. Kubik, and has been the host, presenter,
and producer of internationally distributed educational treatment
videos. Additionally, he is a regular presenter and organizer of
various lymphedema related conferences including the National Lymphedema
Network Conferences (1994-2002), the International Society of Lymphology
Conferences, the Guthrie/Klose Norton Lymphedema Conference (Denver
1999 and Toronto, Canada 2002), the University of Pennsylvania
Abramson Cancer Center/Klose Norton Lymphedema Conference (Philadelphia
2003), and the International Union of Phlebologists (San Diego,
CA 2003). In 2003 he was appointed to the National Lymphedema Network
(NLN) Medical Advisory Committee based in San Francisco, California.
In October 2004 Steve was interviewed at length for the Discovery
Health Channel's television series "Medical Incredible" highlighting
the degree to which lymphedema is often misunderstood and ultimately
misdiagnosed.
Steve was among the first
therapists in the United States to become nationally certified
in lymphedema therapy by the Lymphology Association of North
America (LANA) and was the first and only American lymphedema
therapist to instruct an international group of clinicians at
the world-renowned Foeldi Clinic, Special Clinic for Lymphology,
in Hinterzarten, Germany. |
|
 |
 |
 |
| |
Tracey Towlen, MPT, CLT-LANA, CLM
Executive Director
Tracey graduated from Quinnipiac
University, Hamden, CT. She received her Masters in Physical Therapy
in January 2001. Tracey entered the field of Physical Therapy immediately
following gradation in 2001 at Monmouth Medical Center, Long Branch,
NJ where she was involved in acute care, outpatient rehabilitation,
and lymphedema settings for over 4 years. Tracey received additional
training in Manual Lymph Drainage and Complete Decongestive Therapy
at Klose Norton Training and Consulting in 2001 where she also
received her training as a Certified Elvarex® fitter. She has
since participated in numerous advanced training programs for lymphedema
management including the Lymphedema Management Conference for Certified
Lymphedema Therapists, the University of Pennsylvania Abramson
Cancer Center/Klose Norton Lymphedema Conference (Philadelphia
2003), Staging and Management of Patients with Breast Cancer (2004),
and MLD/CDT Theoretical Review Course (2004). Tracey became nationally
certified in lymphedema therapy by the Lymphology Association of
North America (LANA) in 2004.
Tracey received training as a
Certified Lebed Method (CLM) Instructor in Long Island, NY in 2002.
The Lebed Method is a medically directed dance and movement program
for breast cancer survivors founded by Sherry Lebed Davis. The
Lebed Method helps regain range of motion, increases flexibility,
improves balance both physically and emotionally, helps reduce
lymphedema, and improves quality of life.
Tracey is the founder
of Hope For Life, Inc., a provider of private in-home physical
therapy and wellness programs such as The Lebed Method. She also
conducted a group therapy session in the Goldsmith Wellenss Center
at Monmouth Medical Center. She lectured at the Goldsmith Wellness
Center on lymphedema practices and treatment in 2004. |
|
 |
 |
 |
| |
Christy Kim, MSPT, CLT-LANA
Physical Therapist
Christy graduated from Northeastern
University in Boston, Massachusetts with a Bachelor’s Degree
in Rehabilitation Science and Master’s Degree of Science
in Physical Therapy in 2003. She is a licensed physical therapist
in New Jersey and New York and began her physical therapy career
at Masefield Physical Therapy in Brooklyn, New York. While at Masefield
she provided physical therapy services in an outpatient setting
for patients with orthopedic, sports, and work related injuries
for over two years.
She completed Manual Lymphatic
Drainage and Complete Decongestive Therapy Certification and received
Elvarex Fitter Certification with the Norton School of Lymphatic
Therapy in March 2005. She began treating patients with lymphedema
in a private in-home setting in April 2005. In order to pursue
her interest in treating patients with lymphedema, she joined the
rehabilitation team at Rusk Institute of Rehabilitation Medicine
at NYU Medical Center in New York City. She provided lymphedema
treatment and physical therapy to patients in an outpatient setting
and physical therapy inpatient services to individuals with orthopedic,
post-operative, and neurological diagnoses. She also provided breast
cancer rehabilitation to patients following related surgeries,
chemotherapy, and radiation treatment. Christy became nationally
certified in lymphedema therapy by the Lymphology Association of
North America (LANA) in 2006.[[]] |
|
 |
 |
 |
|